Stockreport

Vigil Neuroscience Announces $40 Million Strategic Investment from Sanofi

Vigil Neuroscience, Inc.  (VIGL) 
PDF - Sanofi to invest $40 million at an as-converted price of $7.44 per share of common stock- - Sanofi to receive an exclusive right of first negotiation for license of C [Read more]